Investment Summary

Sartorius Stedim Biotech Invests In AllPure Technologies

On April 28, 2014, Sartorius Stedim Biotech invested in medical products company AllPure Technologies

Investment Highlights
  • This is Sartorius Stedim Biotech’s 3rd transaction in the Medical Products sector.
  • This is Sartorius Stedim Biotech’s 1st transaction in the United States.
  • This is Sartorius Stedim Biotech’s 1st transaction in Pennsylvania.

Investment Summary
Date 2014-04-28
Target AllPure Technologies
Sector Medical Products
Investor(s) Sartorius Stedim Biotech
Deal Type Stake Purchase

Target

AllPure Technologies

New Oxford, Pennsylvania, United States
AllPure Technologies, Inc. is a designer, manufactures and markets cutting-edge products for biopharmaceutical and pharmaceutical drug developers and manufacturers.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Sartorius Stedim Biotech

Aubagne, France
Category Company
Founded 1870
Sector Internet Software and Services
Employees10,493
Revenue 816.0B EUR (2023)
DESCRIPTION

Sartorius Stedim Biotech is a provider of cutting edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry. Sartorius Stedim Biotech was founded in 1870 and is based in Aubagne, France.

DEAL STATS #
Overall 4 of 19
Sector (Medical Products) 3 of 6
Type (Stake Purchase) 1 of 2
State (Pennsylvania) 1 of 1
Country (United States) 1 of 7
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-16 TAP Biosystems

Royston, United Kingdom

TAP Biosystems Ltd. is a provider of automated cell culture and fermentation systems to the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on: Bioprocess development, Cell therapy & stem cell research, GMP manufacture of biologics and Discovery research.

Buy $45M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-17 BioOutsource

Glasgow, United Kingdom

BioOutsource Ltd. is a provider of contract testing services to the global biopharmaceutical and biotechnology industries. Our core offering includes a comprehensive suite of services which support the testing of biologic and vaccines products throughout development and manufacture.

Buy -
Mergr

Product

Company

Legal